D.E. Shaw & Co’s Endocyte, Inc. Common Stock ECYT Stock Holding History

D.E. Shaw & Co’s Portfolio ECYT Stock Details ECYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-105,000	Closed	-$1.86M	–	4148
2018 Q3	$1.86M	Buy	+105,000	New	+$1.8M	﹤0.01%	2248

Other funds holding ECYT

OTC

Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return

Claro Advisors Boston, Massachusetts $830M AUM 21.8% 1-Year Est. Return

D.E. Shaw & Co's ECYT Position: Q4 2018 in Review

D.E. Shaw & Co sold out of Endocyte, Inc. Common Stock (ECYT) in Q4 2018, closing a stake of 74,788 shares — an estimated $1.33M sold.

D.E. Shaw & Co first reported a position in ECYT in Q1 2014 and held it in 18 quarters. The position peaked at $14.7M in Q1 2018. 2 funds tracked by Wall St. Rank hold ECYT as of Q4 2018.

D.E. Shaw & Co reported no remaining Endocyte, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
D.E. Shaw & Co sold 74,788 Endocyte, Inc. Common Stock shares in Q4 2018, an estimated $1.33M.
D.E. Shaw & Co first reported a position in Endocyte, Inc. Common Stock in Q1 2014 and held it in 18 quarters.
D.E. Shaw & Co's Endocyte, Inc. Common Stock position peaked at $14.7M in Q1 2018.
2 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q4 2018.

Based on D.E. Shaw & Co's 13F filing for Q4 2018, filed 14 Feb 2019.